FIELD: organic chemistry, virology.
SUBSTANCE: invention refers to virology. Formulation contains Erl's glucose-saline solution, amino acid complex with vitamins added, serum of bovine animals, 5% solution of sodium bicarbonate, 0.1% solution of neutral red, 1.5% solution of Bacto™ Agar, demineralized water, penicillin and streptomycin. Composition can be applied for virology analysis and immunoassays for SARS virus detection, specific detection of recovalecent antibodies to SARS agent in blood serum, as well as for evaluation of medicines efficiency in vitro and in vivo in relation to SARS virus.
EFFECT: development of formulation applied for samples evaluation for SARS virus, for recovalecent antibodies to SARS agent in blood serum, as well as for evaluation of medicines efficiency in vitro and in vivo in relation to SARS virus.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION OF AGAR COATINGS FOR DETERMINING MACHUPO - BOLIVIAN HEMORRHAGIC FEVER VIRUS POPULATION CONCENTRATION AND STRUCTURE WITH USING METHOD OF NEGATIVE COLONIES | 2014 |
|
RU2634868C2 |
METHOD FOR DETERMINING ANTIGENIC DIFFERENCES OF ARENAVIRUS GENES OF ARENAVIRIDAE FAMILY | 2018 |
|
RU2729052C2 |
METHOD OF OBTAINING RECOMBINANT ANTIGEN MBP_RBD_6HIS OF SARS-CoV-2 VIRUS WITH C-TERMINAL AFFINITY TAG 6XHIS-TAG, INTENDED FOR USE AS COMPONENT OF REAGENT KIT FOR COVID-19 SERODIAGNOSTICS | 2023 |
|
RU2813324C1 |
1-METHYL-2-PHENYLTHIOMETHYL-3-CARBETHOXY-4-DIMETHYLAMINOMETHYL-5- HYDROXY-6 -BROMOINDOLE MESYLATE ELICITING ANTIVIRAL ACTIVITY AND PHARMACEUTICAL COMPOSITION WITH ITS USAGE | 2004 |
|
RU2255086C1 |
MEDICINAL AGENT FOR TREATMENT OF ATYPICAL PNEUMONIA | 2004 |
|
RU2256451C1 |
STRAIN C/2014 OF MACHUPO VIRUS - AGENT OF BOLIVIAN HAEMORRHAGIC FEVER INTENDED FOR LABORATORY EVALUATION OF EFFECTIVENESS OF MEDICAL REMEDIES IN RESPECT OF THIS PATHOGEN | 2017 |
|
RU2699525C2 |
METHOD FOR DETERMINATION OF INFECTIOUS ACTIVITY OF VIRUSES AT STORAGE | 0 |
|
SU1761801A1 |
METHOD OF OBTAINING INACTIVATED VACCINE AGAINST COVID-19 AND VACCINE OBTAINED BY METHOD | 2023 |
|
RU2810740C1 |
WHOLE VIRION INACTIVATED VACCINE AGAINST SARS-Cov-2 INFECTION AND ITS USE | 2023 |
|
RU2809375C1 |
METHOD FOR CULTIVATION OF FETAL PORCINE CELLS FOR VIROLOGY | 2021 |
|
RU2795135C2 |
Authors
Dates
2008-05-27—Published
2005-11-25—Filed